Back to Search Start Over

The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.

Authors :
Rivera, Donna R.
Henk, Henry J.
Garrett‐Mayer, Elizabeth
Christian, Jennifer B.
Belli, Andrew J.
Bruinooge, Suanna S.
Espirito, Janet L.
Sweetnam, Connor
Izano, Monika A.
Natanzon, Yanina
Robert, Nicholas J.
Walker, Mark S.
Cohen, Aaron B.
Boyd, Marley
Enewold, Lindsey
Hansen, Eric
Honnold, Rebecca
Kushi, Lawrence
Mishra Kalyani, Pallavi S.
Pe Benito, Ruth
Source :
Clinical Pharmacology & Therapeutics; Jan2022, Vol. 111 Issue 1, p283-292, 10p
Publication Year :
2022

Abstract

The purpose of this study was to evaluate the potential collective opportunities and challenges of transforming real‐world data (RWD) to real‐world evidence for clinical effectiveness by focusing on aligning analytic definitions of oncology end points. Patients treated with a qualifying therapy for advanced non‐small cell lung cancer in the frontline setting meeting broad eligibility criteria were included to reflect the real‐world population. Although a trend toward improved outcomes in patients receiving PD‐(L)1 therapy over standard chemotherapy was observed in RWD analyses, the magnitude and consistency of treatment effect was more heterogeneous than previously observed in controlled clinical trials. The study design and analysis process highlighted the identification of pertinent methodological issues and potential innovative approaches that could inform the development of high‐quality RWD studies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00099236
Volume :
111
Issue :
1
Database :
Complementary Index
Journal :
Clinical Pharmacology & Therapeutics
Publication Type :
Academic Journal
Accession number :
154273149
Full Text :
https://doi.org/10.1002/cpt.2453